Study on AUNIP as a Novel Tumor Marker for Cervical Cancer - Trial NCT06118463
Access comprehensive clinical trial information for NCT06118463 through Pure Global AI's free database. This phase not specified trial is sponsored by Lin Yuan and is currently Not yet recruiting. The study focuses on Cervical Cancer. Target enrollment is 300 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Lin Yuan
Qianfoshan Hospital
Timeline & Enrollment
N/A
Jan 01, 2024
Jan 01, 2029
Primary Outcome
AUNIP expression in serum
Summary
To detect the expression of AUNIP in cervical cancer serum, and to clarify its diagnostic and
 prognostic value.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06118463
Non-Device Trial